Your browser doesn't support javascript.
loading
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.
Ajani, J A; Abramov, M; Bondarenko, I; Shparyk, Y; Gorbunova, V; Hontsa, A; Otchenash, N; Alsina, M; Lazarev, S; Feliu, J; Elme, A; Esko, V; Abdalla, K; Verma, U; Benedetti, F; Aoyama, T; Mizuguchi, H; Makris, L; Rosati, G.
Afiliação
  • Ajani JA; GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA.
  • Abramov M; State Institution Russian Scientific Oncology Centre n.a. N.N. Blokhin of RAMS, Moscow, Russia.
  • Bondarenko I; Oncology Department, Dnipropetrovsk Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine.
  • Shparyk Y; Chemotherapy Department, Lviv State Oncology Regional Treatment and Diagnostic Centre Hospital, Lviv, Ukraine.
  • Gorbunova V; Chemotherapy Department, State Institution Russian Scientific Oncology Centre n.a. N.N. Blokhin of RAMS, Moscow, Russia.
  • Hontsa A; Day Staing Department, Chernivtsi Regional Oncology Center, Chernivtsi.
  • Otchenash N; Deparment of Oncology, Kharkiv Regional Clinical Oncology Center, Kharkiv, Ukraine.
  • Alsina M; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Lazarev S; State Healthcare Institution 'Altai Regional Oncology Dispensary', Barnaul, Russia.
  • Feliu J; Department of Oncology, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Hospital Universitario La Paz, Madrid, Spain.
  • Elme A; Department of Oncology, North Estonian Regional Hospital, Harjumaa.
  • Esko V; Cancer Center, East Tallinn Central Hospital, Tallinn, Estonia.
  • Abdalla K; Department of Clinical Oncology, Fundaçaõ PIO XII - Hospital de Câncer de Barretos, Barretos, SP, Brazil.
  • Verma U; Hematology/Oncology Department, University of Texas Southwestern Medical Center at Dallas, Dallas.
  • Benedetti F; Departments of Clinical Development, Taiho Oncology Inc., Princeton.
  • Aoyama T; Departments of Clinical Development, Taiho Oncology Inc., Princeton.
  • Mizuguchi H; Departments of Clinical Research, Taiho Oncology, Inc., Princeton.
  • Makris L; Department of Oncology, Stathmi Inc., New Hope, USA.
  • Rosati G; Medical Oncology Unit, Ospedale San Carlo, Potenza, Italy.
Ann Oncol ; 28(9): 2142-2148, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28911091
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Cisplatino / Fluoruracila Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Cisplatino / Fluoruracila Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos